Literature DB >> 34037427

Salient Constructs for the Development of Shared Decision-Making Tools for HIV Pre-Exposure Prophylaxis Uptake and Regimen Choice: Behaviors, Behavioral Skills, and Beliefs.

Kathrine Meyers1, Yumeng Wu1, Kee-Young Shin2, Jianhua Hou3, Qinghai Hu4, Junyi Duan5, Yao Li6, Xiaoqing He6.   

Abstract

The availability of multiple pre-exposure prophylaxis (PrEP) regimens creates a preference-sensitive choice for individuals weighing alternative HIV prevention strategies. Investigating factors that are associated with PrEP uptake and regimen choice are key to developing tools to support that decision. A cross-sectional survey was offered to 536 participants in a PrEP demonstration project for gay, bisexual, and other men who have sex with men across 3 cities in China, of which 412 completed surveys and were included in the analysis. We conducted bivariable analyses followed by multi-variable logistic regressions to examine factors associated with overall PrEP uptake and PrEP regimen choice. Among the 412 participants, 36.9% were daily PrEP users, 28.4% were event-driven users, and 34.7% were non-PrEP users. Higher levels of education, lower PrEP use stigma, and higher perceived benefits of PrEP were associated with greater PrEP uptake. More frequent sex, higher PrEP adherence self-efficacy, higher endorsement of the belief in elevated efficacy of daily over on-demand PrEP, and lower endorsement of a desire for a PrEP method that is only taken when needed led to greater odds of choosing the daily PrEP regimen. As multiple HIV prevention modalities become available, there is a greater need for a shared decision-making approach to support this preference-sensitive choice of HIV prevention method. Our findings suggest salient constructs to inform the development of shared decision-making tools to support regimen choice.

Entities:  

Keywords:  China; HIV prevention; men who have sex with men; pre-exposure prophylaxis; shared decision making

Mesh:

Year:  2021        PMID: 34037427      PMCID: PMC8215423          DOI: 10.1089/apc.2021.0066

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.944


  54 in total

1.  Low willingness and actual uptake of pre-exposure prophylaxis for HIV-1 prevention among men who have sex with men in Shanghai, China.

Authors:  Yingying Ding; Huamei Yan; Zhen Ning; Xiaofeng Cai; Yin Yang; Rong Pan; Yanqiu Zhou; Huang Zheng; Meiyang Gao; Keming Rou; Zunyou Wu; Na He
Journal:  Biosci Trends       Date:  2016-04-06       Impact factor: 2.400

2.  Internalized homophobia and reduced HIV testing among men who have sex with men in China.

Authors:  Thomas Pyun; Glenn-Milo Santos; Sonya Arreola; Tri Do; Pato Hebert; Jack Beck; Keletso Makofane; Patrick A Wilson; George Ayala
Journal:  Asia Pac J Public Health       Date:  2014-02-18       Impact factor: 1.399

3.  Risk Behavior Not Associated with Self-Perception of PrEP Candidacy: Implications for Designing PrEP Services.

Authors:  Lu Xie; Yumeng Wu; Siyan Meng; Jianhua Hou; Rong Fu; Huang Zheng; Na He; Min Wang; Kathrine Meyers
Journal:  AIDS Behav       Date:  2019-10

4.  "The fear of being Black plus the fear of being gay": The effects of intersectional stigma on PrEP use among young Black gay, bisexual, and other men who have sex with men.

Authors:  Katherine Quinn; Lisa Bowleg; Julia Dickson-Gomez
Journal:  Soc Sci Med       Date:  2019-04-30       Impact factor: 4.634

5.  Accuracy of highly sexually active gay and bisexual men's predictions of their daily likelihood of anal sex and its relevance for intermittent event-driven HIV pre-exposure prophylaxis.

Authors:  Jeffrey T Parsons; H Jonathon Rendina; Christian Grov; Ana Ventuneac; Brian Mustanski
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-01       Impact factor: 3.731

6.  "Support Your Client at the Space That They're in": HIV Pre-Exposure Prophylaxis (PrEP) Prescribers' Perspectives on PrEP-Related Risk Compensation.

Authors:  Sarah K Calabrese; Manya Magnus; Kenneth H Mayer; Douglas S Krakower; Adam I Eldahan; Lauren A Gaston Hawkins; Kristen Underhill; Nathan B Hansen; Trace S Kershaw; Joseph R Betancourt; John F Dovidio
Journal:  AIDS Patient Care STDS       Date:  2017-04       Impact factor: 5.078

7.  Development and field testing of a decision support tool to facilitate shared decision making in contraceptive counseling.

Authors:  Christine Dehlendorf; Judith Fitzpatrick; Jody Steinauer; Lawrence Swiader; Kevin Grumbach; Cara Hall; Miriam Kuppermann
Journal:  Patient Educ Couns       Date:  2017-02-10

8.  On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.

Authors:  Guillemette Antoni; Cécile Tremblay; Constance Delaugerre; Isabelle Charreau; Eric Cua; Daniela Rojas Castro; François Raffi; Julie Chas; Thomas Huleux; Bruno Spire; Catherine Capitant; Laurent Cotte; Laurence Meyer; Jean-Michel Molina
Journal:  Lancet HIV       Date:  2019-11-26       Impact factor: 12.767

Review 9.  Current and Future PrEP Medications and Modalities: On-demand, Injectables, and Topicals.

Authors:  Matthew R Beymer; Ian W Holloway; Craig Pulsipher; Raphael J Landovitz
Journal:  Curr HIV/AIDS Rep       Date:  2019-08       Impact factor: 5.495

10.  Interest in Switching to On-Demand HIV Pre-Exposure Prophylaxis (PrEP) Among Australian Users of Daily PrEP: An Online Survey.

Authors:  Vincent J Cornelisse; Luxi Lal; Brian Price; Kathleen E Ryan; Charlotte Bell; Louise Owen; Edwina J Wright
Journal:  Open Forum Infect Dis       Date:  2019-06-14       Impact factor: 3.835

View more
  1 in total

1.  Determinants of Willingness to Use PrEP Among Gay and Bisexual Men in China Before Implementation: A Structural Equation Modeling Assessment.

Authors:  Tracy Shicun Cui; Benjamin Lane; Yumeng Wu; Jing Ma; Rong Fu; Jianhua Hou; Siyan Meng; Lu Xie; Yuzhou Gu; Xiaojie Huang; Huang Zheng; Yanling Ma; Na He; Kathrine Meyers
Journal:  AIDS Behav       Date:  2022-08-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.